Association of hTcf-4 gene expression and mutation with clinicopathological characteristics of hepatocellular carcinoma

Table 1 The relationship between hTcf-4 mRNA expression and clinicopathological features of the patients

	n	hTcf-4/β-actin	P
AFP
≤ 20 μg/L	16	0.71 ± 0.14	> 0.05
> 20 μg/L	16	0.67 ± 0.12
Cirrhotic nodules
< 0.3 cm	14	0.75 ± 0.11	> 0.05
≥ 0.3 cm	18	0.67 ± 0.14
Tumor size
≤ 5 cm	15	0.66 ± 0.13	> 0.05
> 5 cm	17	0.76 ± 0.12
Capsule
well capsule	14	0.61 ± 0.10	< 0.05
poor capsule	18	0.79 ± 0.10
Metastasis
Yes	15	0.78 ± 0.12	< 0.05
No	17	0.66 ± 0.12

N: number; Yes: tumors with cancerous thrombi in portal vein or intrahepatic metastasis; No: tumors without cancerous thrombi in portal vein and intrahepatic metastasis.